Rest Profoundly Protects Against Cardiac Remodeling and Benets Repair

Cardiovascular disease is a leading cause of morbidity and mortality worldwide 1 . Although rest has long been considered benecial to patients 2 , remarkably there are no evidence-based experimental models determining how it benets disease outcomes. Here, we create a novel experimental rest model in mice, whereby light-induced manipulation of the circadian system briey extends the rest period by 4 hours each morning. We found, in two different cardiovascular disease conditions (cardiac hypertrophy, myocardial infarction), that imposing a short, extended period of rest each day persistently reduces cardiac remodeling, as compared to control mice subjected to only normal periods of rest, supporting the therapeutic benets of rest to slow functional decompensation in heart disease. Mechanistically, rest reduces hemodynamic stress on the cardiovascular system, imposing changes on myolament contractile function in the heart independently consistent within each disease phenotype. Molecular analyses reveal attenuation of cardiac remodeling genes, consistent with the benets on cardiac structure and function. These same cardiac remodeling genes underlie the pathophysiology of many major human cardiovascular conditions, as demonstrated by interrogating open-source transcriptomic data, and thus patients with other conditions may also benet from a morning rest period in a similar manner. In summary, we report that rest is a key driver of physiology, leading to the development of an entirely new eld on the nature of rest, and provide a strong rationale for advancement of rest based therapy for major clinical diseases. baseline, 1- and 4-weeks post-TAC, or at baseline, 1-, 4-, and 8-weeks post-MI using a GE Vivid e90 ultrasound machine (GE Medical Systems) with an L8-18i-D 15 MHz linear array transducer under light anesthesia (1.0% isourane). Images were analyzed on an oine system using EchoPAC (GE Medical Systems). Measurements were taken at the mid-papillary level and used to determine left ventricular internal dimension at diastole (LVIDd), left ventricular internal dimension at systole (LVIDs), % ejection fraction (% EF), % fractional shortening (% FS), interventricular septal wall thickness at diastole (IVSd), left ventricular posterior wall thickness at diastole (LVPWd), and heart rate (HR). For the TAC studies, a total of 44 mice were used (n = 11 mice/group). For the MI studies, 20 mice were used (n = 10 mice/group). At least 5 images per animal were used for analysis, and means are presented.

The data thus far suggest that exposure to a brief extended daily period of rest profoundly preserves cardiac structure and function in two murine models that mirror the clinical features of human cardiovascular disease. Taking advantage of light as the primary zeitgeber regulating daily circadian rhythms of rest and activity, we evaluated the effects of spectral distribution, as the intrinsically photosensitive melanopsin containing retinal ganglionic cells which mediate most of the effects of light on the circadian mechanism are sensitive to short-wavelength (e.g. blue) but not long-wavelength (e.g. red) light [22][23][24] . The sensitivity of the circadian system to light for imposing rest in murine heart disease is unknown.
Analysis of 24 h locomotor activity using running wheel actigraphy revealed that an additional 4 h of normal white light during what would otherwise be the start of the active period, resulted in a 4 h extended rest period ( Fig. 2a-b). Importantly, with the extended period of rest in the morning hours, the animals still maintained a normal circadian period of ~24 h (Fig. 2a) even though the number of hours per day spent at rest were signi cantly increased (Fig. 2c). Moreover, we determined that shortwavelength blue light alone (420-520 nm) was su cient to delay activity onset, while maintaining a normal circadian period of ~24 h (Fig. 2d), thus imposing more hours per day spent at rest ( Fig. 2e-f). In contrast, mice exposed to red light showed no change daily activity patterns, as expected, as the circadian system is not sensitive to long-wavelength light (>620 nm) (Extended Data Fig. 1). These observations are consistent with the notion that the rest model mechanistically co-opts the circadian system to interrogate the bene ts of a brief daily period of rest on cardiac pathophysiology.
In contrast with our ndings in mice subjected to the normal LD 12:12 cycle, we detected reduced hemodynamic load in mice during the extended rest period, by in vivo radiotelemetry. Mice had signi cantly lower systolic (SBP) and diastolic (DBP) blood pressure, concurrent with lower cardiac afterload (mean arterial pressure; MAP) when provided with 4 h of additional rest during the early morning hours (+Rest) (Fig. 2g). Heart rate (HR) was also signi cantly reduced under the rest model, as compared to controls (Fig. 2h). Our mammalian physiology undergoes profound daily rhythms in blood pressure and heart rate that are important for cardiovascular health 25, 26 . A short period of additional rest thus reduces hemodynamic stress on the heart, consistent with the notion that our circadian rhythms critically regulate cardiovascular physiology.
Rest induced contractile function and phosphorylation of sarcomeric myo laments and precision remodeling in a cardiac disease speci c manner The current paradigm of cardiac pathophysiology holds that the cardiac sarcomere is the basic contractile unit of the heart 27 , and that sarcomeric dysfunction drives changes in cardiac muscle contractility central to impaired cardiac function 28 . The structure and function of the cardiac sarcomere is regulated by phosphorylation of the myo lament proteins 28,29 . In heart failure, altered myo lament phosphorylation is a key driver of contractile dysfunction and disease progression 30 . As a result, targeting the post-translational modi cation of cardiac myo laments has become a new frontier in improving cardiac function in heart failure 31 . Our model may provide a novel and promising non-pharmaceutical approach, but the effects of brie y extending morning rest on contractility parameters of the remodeling heart are unknown.
To test for sarcomeric relevance, TAC hearts were rst examined using an actomyosin MgATPase activity assay 32 . As compared to healthy hearts under normal L:D conditions, the TAC hearts had signi cantly reduced maximal MgATPase activity (Fig. 3a), and EC 50 was similarly decreased (Fig. 3b), suggestive of impaired sarcomere activity at high Ca 2+ concentrations. These ndings coincided with the increased cardiac afterload in the TAC hearts (e.g. MAP) (Fig. 3c). In contrast, with the brief additional period of rest, TAC+Rest hearts had better maximal MgATPase activity (Fig. 3d), normalized EC 50 (Fig. 3e), and reduced cardiac afterload (Fig. 3f), SBP, DBP and HR (Extended Data Fig. 2a-b), where values were maintained similar to sham controls. Strikingly, and in accordance with our observations at the sarcomere level, TAC+Rest hearts had signi cantly higher phosphorylation levels of desmin and troponin T (TnT) (Fig. 3g), providing a biological basis underlying reduced stress on the heart. Collectively, these observations are consistent with the notion that the brief morning period of rest offsets pathological myocardial remodeling by preserving contractile function at the level of the cardiac sarcomere.
We next investigated how rest in uences sarcomere function in remodeling myocardium post-MI. As compared to healthy hearts under normal L:D, the MI hearts maintained normal actomyosin MgATPase activity at all levels of calcium (Fig. 3h), however we did note that EC 50 was increased (Fig. 3i), suggestive of a change in myo lament calcium sensitivity, and coinciding with decreased cardiac contractility as demonstrated by reduced dP/dt max and dP/dt min values (Fig. 3j). In contrast, with the brief additional period of rest, MI+Rest hearts had reduced maximal MgATPase activity (Fig. 3k), with no change in EC 50 ( Fig. 3l), suggestive of reduced myo lament energy (ATP) consumption, which coincided with improved cardiac contractility as demonstrated by increased dP/dt max and dP/dt min (Fig. 3m), and by increased SBP and improved left ventricular functional parameters demonstrated by PV loop hemodynamics (Extended Data 2c-g). Moreover, MI+Rest hearts showed improved intrinsic cardiac contractility independent of hemodynamic preload, as evidenced by greater slope of the end-systolic pressure volume relationship (ESPVR) (Extended Data Fig. 2g). Mechanistically, we observed a signi cant decrease in the phosphorylation of myosin binding protein C (MyBP-C), TnT, and tropomyosin (Tm) in MI+Rest hearts ( Fig. 3n), consistent with the reduced myo lament ATPase activity. Thus, rest helps to preserve cardiac contractile function post-MI, which is important for protecting against progression to heart failure. Importantly these data also reveal that rest bene ts the heart in a disease phenotype speci c manner, remarkable precision medicine tailored to bene t different cardiac pathologies.
Rest responsive pathways in experimental and human cardiovascular disease Evidence thus far suggests that rest imposes unique structural and functional bene ts on the remodeling heart. To elucidate a genetic basis for rest acting on the heart, we used mRNA arrays to quantify the cardiac transcriptomes of healthy mice maintained under the brief daily extended rest period. Beginning with a background set of 28,137 known protein-coding mouse transcripts, principal components analyses clearly identi ed two different groups of global gene expression, one from the control hearts and one from the extended rest hearts (Fig. 4a). From this, we de ned "rest gene" as any gene in the extended rest group identi ed as robustly expressed on GeneSpring analyses, with at least a >1.3-fold change versus control hearts. In this context we identi ed 91 rest genes in the heart ( Fig. 4b and Supplementary Table  1). Next, we used the Gene Ontology database as a basis for our pathway network, and found many rest genes encode critical regulators of cardiac growth, renewal and remodeling( Fig. 4c and Extended Data Fig. 3). For example, regulator of calcineurin 1 (Rcan1) 33 , natriuretic peptide B (Nppb) 34 , REL protooncogene, NF-κB subunit (Rel) 35 , transferrin receptor (Tfrc) 36 , Egl-9 family hypoxia inducible factor 3 (Egln3) 37 , ankyrin repeat domain 23 (Ankrd23) 38 , uncoupling protein 3 (Ucp3) 39 , pyruvate dehydrogenase kinase 4 (Pdk4) 40 , actin alpha 1 (Acta1) 41 , and 3-hydroxy-3-methylglutaryl-CoA synthase 2 (Hmgsc2) 42 , all of which play critical roles in the pathophysiology of cardiovascular diseases. These biologically signi cant rest genes were validated by real-time PCR (Fig. 4d).
To test for human relevance, we turned to microarray datasets of control and failing human hearts (Extended Data Table 3). Strikingly, the rest genes and sarcomere gene products identi ed in our experimental rest studies are clear biomarker targets in human heart disease ( Fig. 4e), supporting the notion that rest can bene t both experimental and clinical cardiovascular disease conditions. Seizing upon the recent observation that many clinical drugs target gene products with circadian rhythmicity 43 , we also observed that many of our identi ed rest genes exhibit circadian rhythmicity ( Fig. 4f and Extended Data Table 4), and thus can likely be in uenced by the molecular clock mechanism consistent with the biological basis of our model system. Finally, to infer whether rest may provide bene ts in addition to contemporary drug therapy, we also investigated which of the best-selling and commonly taken heart drugs target rest gene pathways. Notably, 2/3rds of the top prescribed cardiovascular drugs listed by the American Heart Association target rest-responsive gene products pathways ( Fig. 4f and Extended Data Table 4), leading us to speculate that drug e cacy can be improved upon in conjunction with an additional brief period of daily rest.

Discussion
The data presented here are consistent with the general hypothesis that rest plays a key role in cardiac remodeling and improves outcomes. Given the limitations of current preclinical models to study rest, we developed a novel murine model that allows us to recapitulate the clinical phenotypes of human heart diseases and study the physiologic and molecular bene ts of rest on cardiac repair. We postulate that brie y extending daily rest, by using light to co-opt the circadian biology of rodents, plays a critical role in triggering the pro-cardiac responses. Certainly, the importance of circadian rhythms for cardiovascular health has been demonstrated in experimental 20,44,45 and clinical studies 46,47 . However, while studies examining the effects of circadian rhythm disruption 16,19 or disturbed sleep 48,49 on cardiovascular healing provide some insights into exacerbating pathophysiology, they do not help explain how to bene t healing, nor provide feasible strategies for patients with cardiovascular disease. Using multiple approaches in preclinical models of heart disease and human gene data from patients with cardiovascular disease, we uncovered evidence implicating rest on bene ting cardiac structure and function, reducing hemodynamic stress, preserving contractile function at the level of the cardiac sarcomere, that rest acts in a precision therapy manner such that it is disease-phenotype speci c, and we identi ed rest genes that have daily rhythms and underlie human heart disease and are common targets of drug therapies (Fig. 4g). Indeed, our ndings implicate rest as a master mediator of pathways critical in the pathophysiology of cardiovascular disease.
Strategies to add a brief daily period of rest can be applied alongside and to elevate contemporary therapies for heart disease. Our observations are certainly not conclusive for human patients, but they have enormous implications for bene tting treatment of cardiovascular disease, a leading cause of death worldwide. We hope that our preclinical study will stimulate the initiation of an entirely new eld -the nature of rest -along with clinical trials reappraising the value of rest as an important long-term lifestyle approach leading to longer and healthier lives.
Using a remarkably simple strategy, we developed a novel evidence-based murine model to study the bene ts of promoting brief daily rest as cardiovascular disease therapy, and especially during the critical early period of cardiovascular pathogenesis and cardiac repair, and which can have applications to healing from any clinical disease.

Experimental animals
All studies were carried out in accordance with the guidelines of the Canadian Council on Animal Care and were reviewed and approved by the University of Guelph Institutional Animal Care and Use Committee. All animals were housed at the University of Guelph Central Animal Facilities. Standard rodent chow and water were provided ad libitum. Rest and activity were recorded from 8-week-old male C57BL/6N mice (Charles River Laboratories), using individual cages equipped with running wheels (Colbourn Instruments), as described 21,50 , and data were collected and analyzed using ClockLab Software (Actimetrics). Rest was measured as hours per day with < 100 counts of activity. Animals were placed on either i) a "control" normal light (L) dark (D) cycle (LD 12:12), or ii) an extended light cycle to induce rest using white light (LD 16:8), or iii) an extended period of light under red light (>620 nm wavelength; LR 12:12) or iv) "extended rest" induced by blue light (420-520 nm wavelength, LBD 12:4:8, rest model) targeting the circadian system to manipulate rest and activity. Light wavelengths were ltered using blue Roscolux 74 or red Roscolux 27 (Rosco Laboratories) over white uorescent lights (Octron T8; Sylvania). Cardiac hypertrophy was surgically induced by transverse aortic constriction (TAC) as previously described [16][17][18]50 . Myocardial infarction was surgically induced by left anterior descending coronary artery ligation as described 19,51 . All surgeries were performed between zeitgeber time (ZT) 01 and ZT04 to avoid confounding circadian effects, and used the same methods for anesthesia, intubation, and analgesia as previously described, and mice were given a subcutaneous injection of buprenorphine In vivo pressure-volume hemodynamics At 8 weeks post-MI, mice were anesthetized with 4% iso urane, intubated, and ventilated. A 1.2Fr pressure-volume catheter (Transonic) was inserted via the right carotid artery and advanced into the ascending aorta for blood pressure measurements. The catheter was then advanced into the LV. Real time physiologic LV and aortic pressure measurements were recorded on an ADInstrument PowerLab, including left ventricular end systolic pressure (LVESP), diastolic pressure (LVEDP), systolic volume (LVESV), diastolic volume (LVEDV), stroke volume (SV), cardiac output (CO), maximum and minimum rst derivatives of LV pressure (dP/dt max ; dP/dt min ), and systolic/diastolic blood pressures (SBP/DBP).
Mean arterial blood pressure (MAP) was calculated as DBP + (SBP-DBP)/3. After PV measurements were obtained, the inferior vena cava was brie y occluded to block venous return to determine the end-systolic PV relationship 52 . Continuously recorded pressures were analyzed with Lab Chart 7 (Colorado Creeks, USA). A total of 18 mice were used (n = 9 mice/group), with data reported as mean ± s.e.m.

In vivo radiotelemetry
Diurnal cardiovascular hemodynamics was assessed using PA-C10 murine telemetry probes (Data Sciences International) to collect continuous blood pressure and heart rate data from conscious, freely moving mice, as previously described 17,50 . Animals were anesthetized with 4% iso urane, intubated, ventilated (model 687; Harvard Apparatus), and maintained at 2.5% iso urane throughout the procedure.
The right carotid artery was isolated and the telemeter catheter was implanted to the level of the aortic arch via the carotid artery. The telemeter transmitter unit was implanted in a subcutaneous skin pouch and the neck incision was closed using silk 6-0 suture (Covidien). Mice were administered buprenorphine (0.1 mg per kg) analgesia upon awakening and at 8 hours and 24 hours postoperatively. Recordings were initiated at 1 week following telemeter implantation and measurements were collected over three continuous 24-hour cycles for each light condition. Following baseline telemetry recordings, mice were subjected to transverse aortic constriction (TAC) surgery. At 4 weeks post-TAC, measurements were collected over three additional days under each light cycle. Systolic (SBP) and diastolic (DBP) blood pressure, mean arterial pressure (MAP), and heart rate (HR) were analysed using the Data Quest IV system (Data Sciences International). Measurements were taken every 5 min for 30 seconds and averaged into 1-hour bins according to ZT time. A total of 4 mice were used, enabling a paired analysis of the same mice before and after all experimental interventions, with data reported as mean ± s.e.m.

Histology
At 8 weeks post-MI, mice were euthanized following hemodynamic assessments with iso urane and cervical dislocation. Body weight (BW), heart weight (HW) and tibia length (TL) were measured for each animal. Hearts were removed, perfused with 1 M KCl, xed in 10% neutral buffered formalin for 48 h, and para n embedded. Hearts were then sectioned at 5 µm thickness, from apex to base, collecting 10 sections every 300 µm. Sections were stained with Masson's trichrome, mounted using Cytoseal 60 mounting media (Thermo Scienti c) and visualized with a Nikon E600 microscope using Q-Capture software (QImaging; Surrey, BC) and quanti ed using Image J 1.46 (NIH). Infarct thickness was determined from a minimum of 5 measurements/section over equidistant points along the infarct region.
LV diameter was determined from sections collected at mid-papillary level. Relative infarct size was determined by dividing the sum of the endocardial and epicardial circumference occupied by the infarct by the sum of the total LV epicardial and endocardial circumferences. A total of 10 mice were used (n = 5 mice/group), with data presented as mean ± s.e.m.
Myo lament isolation, actomyosin MgATPase assay, and protein phosphorylation At 4 weeks post-surgery. TAC, MI and sham animals were euthanized by iso urane and cervical dislocation at ZT15. Hearts were collected, snap frozen in liquid nitrogen, and stored at -80°C until use.
Cardiac myo laments were isolated by differential centrifugation using the protocol described by Podobed et al. 32 . Actomyosin MgATPase activity in isolated cardiac myo laments was determined using a modi ed Carter assay, as described previously 19,32 . Isolated myo lament proteins were separated using 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and protein phosphorylation levels were quanti ed using the PRO-Q Diamond phosphoprotein gel stain (Invitrogen), following the protocol of Podobed et al. 32 . Gels were then stained with Coomassie to determine total protein. Gel imaging was performed on a Bio-Rad ChemiDoc MP Imaging System (Bio-Rad) and analysed using ImageJ (NIH) with protein phosphorylation normalized to total protein. Samples were run, stained, and imaged at the same time on separate gels, and normalized to actin.

RNA isolation, microarray, and bioinformatics analyses
After 4 weeks under either the rest model or control conditions, healthy mice were euthanized by iso urane and cervical dislocation at ZT07. Hearts were collected and snap frozen in liquid nitrogen and stored at -80°C until use. Total RNA from murine heart tissue was isolated using the miRNeasy Mini Kit (Qiagen), as previously described 50 . RNA quantity and quality were assessed by Nanodrop (260/280 ≥ 2; Thermo Scienti c) and RNA ScreenTape (RIN ≥ 7; Agilent). Whole genome microarray analyses were performed using the Affymetrix GeneChip Mouse Gene 2.0 ST array, which interrogates 35,240 RefSeq coding and non-coding transcripts (GEO Accession: GSE115567). Gene expression analyses were performed on 6 individual mouse heart samples. Bioinformatics analyses were performed using GeneSpring GX v14.9 (Agilent Technologies). Raw .cel les were loaded into a project le with exon analysis and Affymetrix exon expression experiment settings and a biological signi cance work ow analysis. The most recent mouse gene 2.0 ST array annotation technology (MoGene-2_0-st_na36_mm10_2016-07-06) was used to perform all analyses. Raw uorescence data were normalized across all chips using the exon robust multiarray summarization algorithm. Experiment parameters for sample groups and replicate structure were de ned, and launched as a group-level interpretation. Quality control across all samples was assessed by log2(normalized signal values) expression of 8 control hybridization probes across all chips, and group level clustering was analyzed by principal components analysis. The probeset lter parameter was de ned to include all 34,351 probeset entities, then ltered by expression using a lower cut-off of 60 raw uorescence units. Differentially expressed genes were determined by fold change analysis of all entities with ≥ 1.3-fold change in expression between rest vs. control hearts (Supplementary Table 1). Hierarchical cluster analysis of this gene cassette generated heat maps of entity expression relative to control hearts. Gene Ontology (GO) analysis was performed on differentially expressed gene lists using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) Functional Annotation Tool (DAVID Bioinformatics 6.8, NIAID/NIH) 53 . Circos plots were generated using Circos v.0.69-9 54 .
Quantitative real time polymerase chain reaction (qRT-PCR) Analysis of mRNA expression by qRT-PCR was performed on a ViiA7 real time PCR system (Applied Biosystems) using the Power SYBR Green RNA-to-Ct one step kit (Life Technologies) under the following protocol: reverse transcription at 48°C for 30 min and 95°C for 10 min for 1 cycle, followed by ampli cation at 95°C for 15 sec and 60°C for 1 min for 40 cycles, followed by hold at room temperature. The following RT-PCR primer sequences were used, including forward and reverse sequences for each gene, respectively: Rcan1 exon 4 isoform mouse CCCGTGAAAAAGCAGAATGC, TCCTTGTCATATGTTCTGAAGAGGG; Nppb mouse GCGAGACAAGGGAGAACAC, GCGGTGACAGATAAAGGAAAAG; Rel mouse CAGAGTGACTTCAAGGGAAC, GTTAGGCACCGAGTCTTTAG; Tfrc mouse CACTCGCCCAAGTTATATCC, GCACGGTGATACTCATACTG; Egln3 mouse CCCGAACTCTGTACGAAAC, CTGCTTGTGGGATTCTAGC; Ankrd23 mouse TCCAGGGCATGAGAGAAG, GGCTGCTACTGGTAGAAATG; Ucp3 mouse CCCAACATCACAAGAAATGCC, ACAGAAGCCAGCTCCAAAG; Pdk4 mouse CGCCAGAATTAAACCTCACAC, TTCTTGATGCTCGACCGTG; Acta1 mouse AGACCTTCAACGTGCCTG, CGTCCCCAGAATCCAACAC; Hmgcs2 mouse CACCTGCTACTAACCTTG, CAAGAGGACACTTTCAGG; histone mouse GCAAGAGTGCGCCCTCTACTG, GGCCTCACTTGCCTCCTGCAA. Relative gene expression was normalized to histone using the delta delta CT method, as described previously 19,20 .

Human myocardial gene expression microarray analyses
Human myocardial gene expression data were obtained using publicly available datasets from the Gene Expression Omnibus (GEO) database 55 . Raw .cel microarray les were downloaded from 6 independent datasets examining myocardial gene expression from LV biopsies from a total of 140 patients. Datasets included patients with aortic stenosis (AS) 56 , dilated cardiomyopathy (DCM) 57-59 , ischemic cardiomyopathy (ICM) [58][59][60] , and non-failing controls (GEO datasets: GSE1145 (AS), GSE10161 (AS), GSE3585 (DCM), GSE42955 (DCM, ICM), GSE79962 (DCM, ICM), GSE16499 (ICM); see Extended Data Table 3). Raw microarray les were analysed from each dataset, using GeneSpring GX v14.9 (Agilent Technologies Inc.), as described above. All probeset entity lists were then interrogated for restresponsive genes identi ed from our murine studies, and analysed as fold change in expression from non-failing control hearts. See Extended Data Table 3 for n-values and microarray technologies for each dataset.
Cardiac medications targeting rest pathways A list of the top 66 commonly prescribed cardiovascular medications was obtained from the American Heart Association (AHA) website 61 . All molecular drug targets were determined using the DrugBank database 62 . Lists were then curated for target genes with known rhythmic transcripts (JTK P-value < 0.05) based on analyses from mouse heart tissue using the CircaDB database 63 and for rest-responsive genes identi ed from our rest model microarray analyses in the murine heart.

Statistical analyses
Values are presented as mean ± s.e.m. Statistical comparisons were made by paired or unpaired Student's t-test, as applicable. All analyses were performed using GraphPad Prism 8 (GraphPad Software) or Excel (Microsoft). A P-value ≤ 0.05 was considered statistically signi cant. All endpoints, n-values, and statistics are provided in detail in the Figure legends and in the Extended Data.

Data availability
The authors declare that all supporting data are available with the article, extended data, supplementary les, or from the corresponding author upon reasonable request. Microarray data were deposited to the GEO database, accession #GSE115567.
Publicly available microarray datasets were downloaded and analyzed from the GEO database, as described in the methods and outlined in Extended Data Table 3.    increased EC50, (j) concurrent with reduced in vivo cardiac contractility in the MI model. k, Extended rest lowers myo lament ATP consumption, (l) but not EC50, (m) consistent with better in vivo cardiac contractility, and (n) reduced myo lament protein phosphorylation. Murine heart tissue collected at ZT15, 4 weeks post-surgery. n=6/group for ATPase and phosphorylation, n=4/group for in vivo radiotelemetry, n=9/group for in vivo pressure-volume hemodynamics. For MgATPase data *P<0.005, for all other data *P<0.05, by unpaired Student's t-test. Data are represented as mean ± s.e.m. Figure 4